Patents by Inventor Michael P. Rathbone

Michael P. Rathbone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6338963
    Abstract: Disclosed herein are methods directed generally to the control of neural activity and for selectively and controllably inducing the in vivo genetic expression of one or more naturally occurring genetically encoded molecules in mammals. More particularly, the present invention selectively activates or derepresses genes encoding for specific naturally occurring molecules such as neurotrophic factors through the administration of carbon monoxide dependent guanylyl cyclase modulating purine derivatives. The methods of the present invention may be used to affect a variety of cellular and neurological activities and to therapeutically or prophylactically treat a wide variety of neurodegenerative, neurological, and cellular disorders.
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: January 15, 2002
    Assignee: NeoTherapeutics, Inc.
    Inventors: Alvin J. Glasky, Michael P. Rathbone
  • Patent number: 5447939
    Abstract: Disclosed herein are methods directed generally to the control of neural activity and to the treatment of neural disorders. More particularly, the present invention is directed to methods for the modification of mammalian neural activity through the administration of carbon monoxide dependent guanylyl cyclase modulating purine derivatives. The methods of the present invention may be used to affect a variety of neurological activities and to therapeutically or prophylactically treat a wide variety of neurodegenerative and neurological disorders.
    Type: Grant
    Filed: July 25, 1994
    Date of Patent: September 5, 1995
    Inventors: Alvin J. Glasky, Michael P. Rathbone